Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

NIA innovation Sapientia™ delivers diagnostic reports to NHS Genomic Medicine Centres

13 September 2016

Congenica has announced the successful delivery of diagnostic reports to the NHS Genomic Medicine Centres, thanks to its analytics and interpretation software platform, Sapientia™ – one of 17 innovations which formed part of the 2015/16 NHS Innovation Accelerator’s successful cohort.

Congenica is one of three companies working closely with Genomics England to deliver genemo interpretation at scale. Genome interpretation software analyses a participant’s genome sequence to support clinicians in identifying the likely cause of someone’s rare disease.

Sapientia™ was required to go through a comprehensive and competitive evaluation process and proved to be able to deliver the state-of-the-art annotation, interpretation and reporting services required for the 100,000 Genomes Project. The software has now been deployed in the secure Genomics England datacentre.

Dr Damian Smedley, Director of Genomic Interpretation at Genomics England, said: “As the 100,000 Genomes Project picks up pace, with over 10,000 genomes now sequenced, it is essential that huge amounts of genomic data can be analysed accurately. We are now providing high quality genome interpretation to assist NHS clinicians and Congenica is helping us do that. Its Sapientia™ technology is in place to quickly analyse thousands of genomes and provide meaningful feedback for patients.”

Dr Tom Weaver, CEO of Congenica, commented: “The 100,000 Genomes Project is a ground-breaking endeavour and has helped to drive the development of robust tools and a secure processing environment. We are delighted that Sapientia™ has been validated by Genomics England and we have a proven pathway in place to receive patient data and rapidly deliver the diagnostic reports.”

Sapientia™ is one of 17 companies selected for the 2015/16 NHS Innovation Accelerator (NIA). The NIA, now in its second year, supports some of the best healthcare innovators with evidence-based innovations to help improve health outcomes and give patients access to the latest products, services and technology at lower cost. The NIA is an NHS England initiative hosted by UCLPartners in partnership with the country’s 15 Academic Health Science Networks (AHSNs). Outcomes to date include 17 Fellows with tried and tested innovations participating in the programme, generation of almost £17millon in funding, and 345 additional NHS providers and commissioners now using the NIA innovations.

For more information visit